Genomic health, inc (GHDX)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income

56,590

50,121

42,451

25,677

18,646

4,230

-6,826

-3,857

-4,384

-5,013

-8,374

-13,919

-18,006

-27,029

-30,166

-33,308

-36,840

-31,259

-26,640

-24,592

-27,694

-20,943

-19,319

-12,757

-1,429

1,795

6,589

8,249

8,849

8,361

8,909

7,846

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

13,195

12,960

12,926

12,669

12,534

12,549

12,507

11,759

10,852

10,002

9,161

8,933

8,647

8,032

7,520

7,069

6,749

6,782

6,841

6,870

6,751

6,666

6,536

6,324

6,267

5,854

5,481

5,471

5,778

6,368

6,952

7,310

0

0

0

Employee stock-based compensation

24,618

23,536

22,185

21,090

20,741

20,295

20,337

20,256

19,458

19,216

18,866

18,303

18,052

17,267

16,371

16,005

15,997

16,055

16,358

16,538

17,208

17,579

17,454

17,457

17,142

16,187

15,769

15,104

13,737

13,242

12,511

11,735

0

0

0

Write-off of previously capitalized software costs

-

-

-

2,347

0

0

0

-

-

-

-

-

-

-

-

635

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

2,358

0

0

0

-

-

-

-

56

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

0

0

0

-

-

-

-

-35

0

0

0

-

-

-

-

80

40

46

103

51

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Outside director restricted stock awarded in lieu of fees

225

200

200

200

200

200

200

200

200

200

200

200

200

200

200

200

210

220

230

230

230

230

230

230

222

202

182

172

0

0

0

-

-

-

-

Gain on sale of corporate debt securities

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of equity securities

-

-

-

-

-

-

-

2,807

4,006

4,006

4,682

3,208

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discount on convertible promissory note

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized net gain on revaluation of equity investments

-

0

1,197

-

-

0

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit from unrealized gain on available-for-sale marketable securities, net

-

-

-

-

-

-

-

820

0

0

0

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit from unrealized gain on available-for-sale marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share of loss of equity method investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-98

-144

-191

-180

-165

0

0

0

Changes in assets and liabilities:
Accounts receivable

4,322

5,325

12,681

6,247

1,846

2,432

-2,149

-4,018

1,902

-1,184

-4,236

-1,985

-72

711

3,850

2,248

2,787

1,129

6,078

5,470

5,373

5,081

1,856

7,193

5,668

4,991

6,208

1,176

-2,720

2,330

4,575

6,771

0

0

0

Prepaid expenses and other assets

2,186

3,089

4,814

2,464

917

1,409

1,444

-64

951

1,973

3,354

4,556

2,365

2,626

-480

1,292

-116

-153

1,196

-741

583

697

992

1,448

953

713

1,994

1,599

1,870

1,580

739

633

0

0

0

Accounts payable

-5

1,819

3,220

8,374

-2,114

280

65

-2,308

3,116

-50

80

-4,579

795

-689

-1,731

949

-1,503

-37

-1,143

985

3,306

2,718

4,503

1,238

93

204

757

-2,144

670

1,594

-1,511

3,057

0

0

0

Accrued compensation and employee benefits

2,802

4,341

126

9,504

4,513

395

2,804

-2,947

-56

841

-949

5,661

3,871

2,516

3,670

4,531

6,270

2,677

3,881

3,824

2,556

2,530

2,341

1,886

1,869

2,437

1,414

1,951

1,203

1,637

1,195

2,222

0

0

0

Accrued expenses and other liabilities

-2,097

3,189

2,021

2,573

4,000

1,270

782

4,164

107

-530

-563

1,645

-2,398

88

-4,807

-2,963

1,972

2,122

7,903

3,088

1,299

1,440

-284

1,297

1,539

2,392

1,833

1,608

1,208

962

1,927

-1,250

0

0

0

Deferred revenues

0

0

0

-

-

-

-

-

-

-

-

-431

-223

-290

106

96

62

251

260

-251

-945

-5

-45

212

-108

-1,112

-1,639

-1,686

-988

-1,230

-1,216

-1,203

0

0

0

Net cash provided by operating activities

91,454

89,034

66,613

76,562

61,120

40,944

36,112

30,602

24,277

23,504

19,569

13,450

8,455

695

-9,903

-11,831

-9,963

-10,494

-5,116

2,287

-1,592

5,985

10,176

8,552

18,886

22,168

22,147

25,962

31,698

27,418

23,796

22,601

0

0

0

Investing activities
Purchases of property and equipment

19,118

16,110

10,818

10,076

9,826

9,444

10,368

13,276

21,401

20,964

19,619

19,786

16,215

20,854

24,425

23,483

20,923

16,284

13,655

10,455

9,137

10,272

9,960

11,008

11,345

10,978

9,931

10,056

7,812

6,835

6,348

6,183

0

0

0

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

280,940

232,751

188,511

172,563

137,626

123,299

112,693

109,249

101,370

84,128

78,114

69,722

78,642

69,327

57,676

76,743

79,184

81,447

104,748

96,800

107,490

118,259

112,220

107,183

113,988

112,807

98,828

103,570

106,007

104,816

111,497

133,993

0

0

0

Maturities of marketable securities

166,278

155,659

148,847

103,979

99,325

91,392

78,571

71,802

74,902

56,682

60,250

66,757

83,191

92,206

89,016

106,439

92,589

91,596

110,590

94,910

114,283

119,460

117,282

116,169

108,747

95,263

85,987

90,160

86,156

105,091

103,819

112,003

0

0

0

Proceeds from sales of corporate debt securities

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

10,155

14,755

14,755

16,293

9,717

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,300

0

0

0

Net cash used in investing activities

-110,420

-69,842

-29,622

-81,105

-52,627

-45,851

-46,490

-42,558

-33,104

-39,737

-27,272

-19,126

-12,613

7,212

10,564

6,283

-7,471

-8,130

-9,691

-14,223

-9,227

-13,942

-9,882

-7,006

-19,918

-32,875

-27,529

-28,223

-29,072

-6,960

-14,026

-30,473

0

0

0

Financing activities
Proceeds from issuance of common stock under stock plans

34,389

30,509

34,971

26,250

23,080

21,802

16,859

21,776

22,590

22,460

22,447

17,010

13,536

12,375

10,450

12,197

12,093

13,789

13,413

12,030

11,880

11,214

14,426

16,588

16,960

20,468

19,304

18,764

17,052

12,806

9,064

9,558

0

0

0

Withholding taxes related to restricted stock units net share settlement

12,558

12,529

12,515

5,498

5,266

5,174

5,162

4,697

4,739

4,680

4,676

3,469

3,389

3,373

3,344

3,842

3,887

3,908

3,909

3,647

3,604

3,585

3,576

2,845

0

0

0

-

-

-

-

-

-

-

-

Payments on finance lease liabilities

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

21,676

17,877

22,405

20,752

17,814

16,628

11,697

17,079

17,851

17,780

17,771

13,541

10,147

9,002

7,106

8,355

8,206

9,881

9,504

8,383

8,276

7,629

10,850

13,728

-17,146

-13,485

-14,512

-12,603

17,052

12,806

9,064

9,558

0

0

0

Net increase in cash, cash equivalents and restricted cash

2,710

37,069

59,396

16,209

26,307

11,721

1,319

5,123

9,024

1,547

10,068

7,865

5,989

16,909

7,767

2,807

-9,228

-8,743

-5,303

-3,553

-2,543

-328

11,144

15,274

-18,178

-24,192

-19,894

-14,864

19,678

33,264

18,834

1,686

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

219

243

0

0

0

Non-cash investing and financing activities
Accrued purchases of property and equipment

2,282

1,611

2,988

1,110

236

-541

-1,236

717

-969

2,852

3,647

1,452

3,521

1,582

1,637

3,847

5,063

4,415

2,560

1,809

881

547

1,516

1,138

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of investments

-1,754

-387

-205

-454

0

0

0

-

-

-

-

-

-

-

-

4,269

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-